Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Z9JY
|
||||
| Former ID |
DNC013664
|
||||
| Drug Name |
[R-(-)-Apomorphine-2-yl]-(2'-hydroxy-ethyl)ether
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529349] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C19H21NO4
|
||||
| Canonical SMILES |
CN1CCC2=C3C1CC4=C(C3=CC(=C2)OCCO)C(=C(C=C4)O)O
|
||||
| InChI |
1S/C19H21NO4/c1-20-5-4-12-8-13(24-7-6-21)10-14-17(12)15(20)9-11-2-3-16(22)19(23)18(11)14/h2-3,8,10,15,21-23H,4-7,9H2,1H3/t15-/m1/s1
|
||||
| InChIKey |
MLSWBRKIYGJEGT-OAHLLOKOSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | D(2) dopamine receptor | Target Info | Inhibitor | [529349] | |
| Dopamine D1 receptor | Target Info | Inhibitor | [529349] | ||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Dopamine receptor mediated signaling pathway | |||||
| Nicotine pharmacodynamics pathwayP05912:Dopamine receptor mediated signaling pathway | |||||
| PathWhiz Pathway | Dopamine Activation of Neurological Reward System | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.